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1. INTRODUCTION 
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1.1. Sleep  
For decades sleep has been a research subject perceived as a big mystery (1). It was 
thought to be a passive state, but later we have found that sleep is a very active phase.  
We sleep around one third of our life (2) so a good quality and quantity of sleep has a 
huge impact on our health and emotions (1). But, why is that so? What is happening during 
sleep and why is it so important for human kind? There are a lot of unanswered questions 
concerning sleep and we still do not have a complete theory explaining it. But during the latest 
years sleep studies and sleep medicine as a discipline have grown, and now we know a lot more 
about sleep, its functions, physiology and pathology.  
Many have tried to define sleep, but we still strive to get one good definition. The 
definition adopted in this thesis is that sleep is defined on the basis of both the physiological 
changes that occur in the brain's electrical rhythms and the behavior of the person (1). The 
criteria for the behavior is reduced response to external stimulation, lack of mobility or slight 
mobility, characteristic sleeping posture, elevated arousal threshold, reversible unconscious 
state and an impaired cognitive function (2,3).  
 
 
1.1.1. Sleep stages 
Electroencephalography (EEG), electro-oculography (EOG), and electromyography 
(EMG) are used to measure the physiological criteria of sleep. With these three measurements 
sleep is divided into two states:  
• Non rapid eye movement (NREM) sleep which accounts for 75-80% of sleep time in 
adults (1) and can be further divided into three stages, N1, N2 and N3 (2); 
• Rapid eye movement sleep (REM) accounting for 20-25% of sleep in adults (1). 
 
EEG, EOG and EMG will show a different pattern between being awake (Figure 1) and 
during sleep (Figures 2-5), but there will also be a difference between the sleep stages. The 
characteristics of the sleep stages are summarized in Table 1. 
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Table1. Characteristics of sleep stages. 
 
REM, rapid eye movement, SEM, slow-rolling eye movements.  
Taken from Claudio Bassetti, Zoran Dogas and Philippe Peigneux. Sleep medicine textbook.1st 
ed. Regensburg: European Sleep Research Society; 2014 (3).  
 
 
 
Figure 1. EEG in wake stage. A representative epoche (30 seconds) from whole night 
polysomnography; recording taken from Split Sleep Medicine Center patient recording 
database. 
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Figure 2. Sleep stage N1 represents the transition from wakefulness to sleep and the arousal 
threshold is lowest in N1 (4). A representative epoche (30 seconds) from whole night 
polysomnography; recording taken from Split Sleep Medicine Center patient recording 
database. 
 
 
 
Figure 3. Sleep stage N2 is the sleep stage which in adults accounts for the greatest proportion 
of total sleep time. A representative epoche (30 seconds) from whole night polysomnography; 
recording taken from Split Sleep Medicine Center patient recording database. 
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Figure 4. N3 stage. This stage is deep sleep. Nightmares, sleepwalking and bedwetting may 
occur. If there is waking in this stage, the feeling of disorientation may be felt for a few 
minutes. A representative epoche (30 seconds) from whole night polysomnography; recording 
taken from Split Sleep Medicine Center patient recording database. 
 
 
 
Figure 5. REM sleep is similar to the wake EEG, but without any postural muscle tone. A 
representative epoche (30 seconds) from whole night polysomnography; recording taken from 
Split Sleep Medicine Center patient recording database. 
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The two states, NREM and REM sleep, are alternating in a cyclic manner where each 
cycle lasts from 90-120 min and are in a total of 3-5 cycles in adults. In the sleep cycles not all 
of the sleep stages will necessarily be presented (4). In the first cycle N1 will be presented, 
then the following cycles can miss stage. During the second half of the night, there is usually 
just an alteration between stage N2 and REM.  
N1 stage (Figure 2) is the first sleep stage and is known as the light sleep. In this stage 
the brain activity will slow down and the muscle tone will slowly decrease. This is also where 
there can be a feeling of falling and there will be a sudden muscle contraction. It is easy to 
wake up from this stage (5). The percentage of N1 sleep stage is 2-5% of the total sleep time 
(4). Slow rolling movements of the eyes can be seen in N1 stage, similar as during drowsiness 
with eyes closed.  
 In N2 stage (Figure 3) the eyes stop moving and the brain activity further slows down. 
The body temperature and the heart rate decreases (5). The slow rolling movements of the eyes 
disappear during the N2 stage. The percentage of N2 sleep stage is 45-55% of total sleep time 
(4). 
N3 stage (Figure 4) is known as deep sleep stage. In this stage nightmares, sleepwalking 
and bedwetting may occur. If there is a waking in N3 stage, the feeling of disorientation for a 
few minutes following waking may be felt (5). The percentage of sleep stage N3 should be 5-
20% (4). 
The remainder of the night (about 20-25% of the total sleep time) is carried out in REM 
stage (4), shown in Figure 5. During the REM phase we can see the classic rapid eye 
movements in all directions. These sharp deflections in the EOG can also be seen during 
wakefulness with open eyes. The EOG in REM sleep will have two components: tonic which 
is without rapid eye movements and phasic where there is rapid eye movement (4). The density 
of the eye movements is increasing progressively towards the later REM sleep stages (4). There 
is also muscle atonia where the brain stem neurons inhibit spinal motor neurons (2). The muscle 
atonia is caused by the ventral portion of the sublaterodorsal nucleus (SLD). The SLD neurons 
increase firing during REM sleep and are firing at their maximum. They are glutamatergic and 
produce the muscle atonia by activating inhibitory interneurons in the spinal cord and the 
ventral medulla (6). 
Other important features of REM sleep are phasic changes in blood pressure and heart 
rate, irregular respiration and phasic tongue movements. Moreover, periods of apnea or 
hypopnea (3,4) may appear and be even more expressed than during NREM stages.  
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One of the main functions of REM sleep is consolidation of learning and memory by 
regulation of neuronal synapses and facilitation of neuronal plasticity. The support to this idea 
is brought by results of many animal studies showing that REM sleep deprivation impairs 
formation of spatial and emotional memories. 
There are some speculations that REM sleep also prepares wakefulness by stimulating 
the central nervous system. This belief raises from the fact that virtually all REM stages are 
immediately followed by wakefulness, that humans and animals are more alert when woken 
from the REM stage compared to the deep NREM stages and that the amount of REM stages 
increase towards the end of sleep (6). 
Newborns spend a majority of sleep time in a REM-like sleep stage. It is called active 
sleep in newborns because of the lack of cortical EEG features present in adult sleep. This led 
to a hypothesis that REM sleep might be important for the development of the brain. 
Researches also suggest a possibility that muscle twitching, that occurs against a background 
of muscle atonia, functions to aid sensorimotor system development. During these twitches 
multiple brain regions are activated. More specifically, hippocampus, cerebellar cortex and the 
red nucleus are all activated during REM sleep, but not during similar motor activity in 
wakefulness (6). 
 
 
1.1.2. Neurophysiological regulation of sleep 
Concerning physiological changes during sleep several neurochemical systems are 
included. The ascending reticular activating system (ARAS), a structure composed of several 
nuclei and neural circuits, is believed to play an important role in regulation of sleep and 
wakefulness, as well as sleep-wake transition (7). It consists of dopaminergic, serotonergic, 
noradrenergic, histaminergic, cholinergic, glutamatergic, and orexin hypothalamic neurons 
that all exert direct and indirect influences on cerebral cortex, promoting wakefulness. More 
precisely, serotonergic neurons mainly located in the dorsal raphe nucleus, noradrenergic 
neurons in the locus coeruleus and cholinergic neurons in the pontine brainstem are all 
included, as shown in Figure 6. There are also systems located more rostrally in the forebrain: 
cholinergic neurons in the basal forebrain, histaminergic neurons localized in the 
tuberomammillary nucleus (TMN) and the orexin system in the tuberal hypothalamus, which 
are the first neurons that excite all the other wakening systems (7).  
During sleep, GABAergic and galanin-containing neurons in the ventral lateral preoptic 
area (VLPO) of the anterior hypothalamus inhibit neurons of the ARAS including: 
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• histaminergic neurons in the TMN; 
• hypothalamic orexin neurons;  
• brainstem serotonergic, noradrenergic, dopaminergic and cholinergic neurons.  
Inhibition of the all above mentioned structures of the ARAS promotes NREM sleep. 
During REM sleep, monoamines, particularly noradrenaline and serotonin, are even 
further reduced. This leads to increased cholinergic inputs to the thalamus, resulting in EEG 
appearance of arousal. Brainstem circuits include neurons that inhibit tonic muscle activity 
during REM sleep (7).  
The 24-h circadian rhythm serves to coordinate the external world with the internal 
time. It is a rhythm in physiology and behavior that is generated by internal molecular clock. 
It is known that the most important regulator of the circadian rhythm is the suprachiasmatic 
nucleus (SCN) in the anterior hypothalamus. The SCN’s task is to synchronize the peripheral 
tissues that contain the molecular clock machinery required for local circadian oscillations and 
rhythmic gene expression (8). 
For proper functioning, the circadian network needs to receive and respond to different 
time signals, Zeitgebers. The most important example of the Zeitgebers is light (9). A 
behavioral manifestation of the circadian rhythm, expressed mostly as a person's propensity to 
sleep at a particular time during the 24-hour period, is known as chronotype. Early types (larks) 
or late types (owls) are the extremes of different chronotypes. The difference is influenced by 
genetics, development and by light. Studies have shown that mutations in Cry1 are linked to 
Familial Delayed Sleep Phase syndrome (9). However, any disturbance of the circadian clock 
and rhythm can lead to major health complications like metabolic syndrome, psychiatric illness 
and cognitive impairment (9).  
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Figure 6. Differences in central nervous system activity in NREM and REM sleep.  
Taken from Spinal cord section modified from DeArmond SJ, Fusco MM, Maynard MD. 1989. 
Structure of the Human Brain: A Photographic Atlas. 3rd Ed. Oxford, New York (10).  
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1.2. Diagnostic procedures in sleep medicine 
 
 
1.2.1. Screening tests  
 The screening tests are frequently used in sleep medicine to assess the risk for sleep 
disorders and to measure subjective sleep quality (4). The most frequently used screening tests 
that are going to be described in this thesis are: Berlin questionnaire, STOP-BANG 
questionnaire, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Stanford 
Sleepiness Scale. 
 
 
Berlin questionnaire (BQ)  
This questionnaire was constructed in 1999 and its goal is to identify risk factors for 
sleep apnea (11). It can be self-administered, it is easy to use and can quickly identify high and 
low risk sleep disordered breathing (12).   
The Berlin questionnaire consists of 10 questions and includes additional information 
about weight and height. The questionnaire is divided into 3 categories: first category contains 
5 questions about snoring and cessation of breathing, the second category consists of 4 
questions about excessive daytime sleepiness and the last category has 1 question about arterial 
hypertension (13). If there are 2 or more positive categories in this test, it indicates high risk of 
OSA (13). Study conducted on clinical population demonstrated that BQ had moderate to low 
sensitivity, specificity, positive and negative predictive values, depending on the OSA severity 
(14). However, to achieve higher predictive properties of the Berlin questionnaire, the patient's 
bed partner or roommate should also be asked to confirm the questions concerning snoring, if 
possible (15).  
 
 
STOP-BANG questionnaire  
This questionnaire was developed in 2008 and was originally meant to screen for OSA 
in the surgical population (16). The goal was to make an easy to use, reliable and concise tool 
for screening patients having increased risk for OSA (17). 
The STOP questionnaire contains 4 questions and the mnemonic stands for STOP: S is 
for Snoring, T stands for Tiredness, O is for Observed apnea and P is for High blood pressure. 
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BANG defines demographic items where B stands for BMI, A for Age, N for Neck 
circumference and G for Gender (male) (16). 
In the STOP questionnaire, a score between 0-1 indicates a low risk for OSA, and a 
score of 2 or more indicates high risk for OSA. With the use of the extended form of the 
questionnaire (STOP-BANG), predictive properties of the questionnaire are better in 
comparison to the STOP questionnaire. In the STOP-BANG questionnaire, a score of 0-2 
indicates a low risk for OSA, a score of 3-4 indicates moderate risk, and a score from 5-8 
indicates a high risk for moderate to severe OSA (17). The sensitivity of the STOP-BANG 
score ≥ 3 to predict OSA depends on the OSA severity and is 83.9% for mild OSA, 92.9% for 
moderate OSA, and even 100% in the group of severe OSA patients (16).  
In conclusion, due to the high sensitivity and its simplicity this test is highly used in 
OSA patients (16). 
 
 
Pittsburgh sleep quality index (PSQI)  
This questionnaire is the most widely used generic measure of sleep quality in both 
research and clinical settings and was created in 1988 (18). The main goals to develop PSQI 
were to provide reliable, valid and standardized subjective measure of sleep quality which will 
be able to discriminate between “good” and “poor” sleepers, providing an assessment of 
different sleep disturbances affecting sleep quality. Moreover, the authors aimed to provide a 
questionnaire that's easy for both, patients to use and for doctors to interpret (19). It is a self-
rated questionnaire which goal is to assess the subjective sleep quality and sleep disturbances 
over 1 past month (19). It was originally created in English, but it is now translated into other 
languages and proven both reliable and valid when translated (20).  
 
 
Epworth Sleepiness Scale (ESS)  
ESS was published in 1991 and its goal is to measure general levels of daytime 
sleepiness (21). It is the most used subjective sleepiness scale in clinical practice. It is easy to 
use, and it can be performed by the patient without any help from the physician (22).  
ESS has a good test-retest reliability and correlates with the results on the other 
subjective sleepiness scales. It shows improvement in treatment studies of patients with sleep 
apnea and narcolepsy. There is also a positive correlation with the likelihood of falling asleep 
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behind the wheel (22). There is a weak correlation between ESS and OSA severity, but it is 
still considered the best tool for awareness of sleepiness (21).  
 
 
Stanford Sleepiness Scale (SSS)  
SSS goal is to measure current subject’s sleepiness level (23). It consists of 7 degrees 
of severity (22), ranging from very alert to excessively sleepy (23). The SSS measures 
sleepiness at a very particular moment. This test is better at monitoring sleepiness in one 
specific person over time than using it to compare different individuals. SSS is sensitive to 
daily activity changes in sleep inclination and deprivation (4). It can be used repetitively, and 
can be repeated in short intervals, unlike the ESS (22). 
 
 
1.2.2. Polygraphy (PG)/polysomnography (PSG) 
Polysomnography is a method that was developed to physiologically describe and 
examine human sleep (24). PSG consists of continuous and simultaneous recording of multiple 
monitors: EEG, ECG, EOG, EMG, airflow and oxygen saturation are all included (4). The 
records used in PSG are shown in Figure 7. 
PSG is an expensive, time consuming and sophisticated examination and is not always 
necessary. Portable monitoring such as polygraphy has been introduced as a substitute in 
patients suspected of having OSA (25). It can be more convenient for the patient due to the fact 
that they can sleep at home, and it also has a lower cost compared to PSG. Still, it is not as 
accurate as PSG (4) and therefore PSG is still the gold standard in diagnosing OSA (25).  
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Figure 7. PSG measurements.  
Taken from Amsleep.org [Internet] The American sleep apnea society. Available from 
https://amsleep.org/ (26). 
 
 
1.3. Sleep disorders 
Sleep disorders are one of the most common health complaints for the clinicians. 
Around half of the adults in the western world experience intermittent sleep disturbance, and 
15-20% of them report chronic sleep problems (18).  
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Enough quality sleep is necessary for optimal health but also for safety. Alteration in 
timing of sleep and amount of sleep are associated with many different diseases (27), such as 
cardiovascular diseases.  
 
 
1.3.1. Obstructive sleep apnea  
Obstructive sleep apnea (OSA) is an increasingly recognized and treated sleep disorder 
It is a common disorder and an important cause of morbidity and mortality (28). OSA will be 
the main disorder discussed in this thesis.  
The disorder is characterized by repetitive episodes of partial (hypopnea), or complete 
(apnea) upper airway obstruction during sleep (29). The anatomy of the upper airways during 
normal breathing and OSA is shown in Figure 8 (30). 
 
  
Figure 8. Normal breathing during sleep and obstructive sleep apnea.  
Taken from MayoClinic.org [Internet]. May Clinic. Available from 
https://www.mayoclinic.org/diseases-conditions/obstructive-sleep-apnea/symptoms-
causes/syc-20352090 (30).   
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This is accompanied by intermittent hypoxemia, increased respiratory effort, and sleep 
disturbance (29). The main manifestations of this condition are respiratory pauses during sleep, 
followed by loud snorts (29). The clinical impacts beside snoring are headaches when patient 
wakes up (31), daytime sleepiness (5), frequent nightmares (29), decrease of cognitive 
performance (32), and an extreme burden on cardiovascular and metabolic systems. The 
frequency of anxiety in OSA patients is also higher than in the general population (29).  
Some studies suggest that OSA prevalence is as much as 2-4% in men and 1-2% in 
women of average age (32). But there are reasons to think that there is a higher number and a 
lot of unreported cases. The risk of getting OSA increases with age and obesity is seen in as 
much as 70% of OSA patients (34). In addition, male gender is one of the most important risk 
factors for this syndrome (29), although it can occur in any age, body type and gender.  
OSA is defined and diagnosed by using apnea-hypopnea index (AHI). It is provided 
from overnight PSG or PG and is calculated as the number of episodes of breathing cessation 
per hour of sleep. Usually OSA is diagnosed if the AHI is above 5. AHI between 5 and 15 
indicates mild OSA, between 15 and 30 indicates moderate OSA and above 30 indicates severe 
OSA. Other biomarkers that are monitored during PG/PSG include measures of hypoxemia, 
measurement of sleep disruption and the duration of obstructive events (34). The activity of 
the pontomedullary pacemaker neurons is preserved, so the thoracic muscles are innervated 
properly, and their activity can be seen in EMG record (33).  
The degree and the frequency of the obstructions will have a great impact on the 
severity of the clinical presentation of the patient. Tiredness, sleepiness and sleeping during 
the day can affect both social life and work. In some of the more serious cases dangerous 
situations could easily arise. About 7% of motor vehicle accidents for a population of male 
drivers involved in a motor vehicle accident are attributable to OSA (35). OSA patients also 
have nearly twofold increased odds of work accidents (35). 
A new and upcoming field is the study of genetics and OSA. Unfortunately, these 
studies have been lagging far behind studies done on other chronic diseases and their genetic 
involvement. There are good reasons to believe that OSA is heritable, and there is evidence of 
both a direct genetic contribution to OSA susceptibility and indirect contributions (34). Indirect 
contribution would be phenotypes such as obesity, specific craniofacial structure, impaired 
neurological control of upper airway muscles and of sleep and circadian rhythms (34). 
However, neither indirect, nor direct genetic factors are believed to be inherent following 
Mendelian patterns and many candidate genes that interact with many environmental factors 
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are involved (34). For example, polymorphisms in TNF-α, as well as mutations in PTGER3, 
IL-6, and e-NOS genes are seen as a risk factor for OSA (34).  
 
 
1.3.1.1. Comorbidities 
The obstructive events can lead to different notorious physiological consequences seen 
in OSA patients. Inflammation, oxidative stress, hypoxemia, sleep fragmentation and an 
increased sympathetic tone all together gives a higher risk for insulin resistance which can 
further lead to metabolic and cardiovascular diseases (36).  
The upper airways, from the nares to the larynx, is a flexible and collapsible tube. 
Activation of dilator muscles maintains the upper airway patency to counteract factors that 
promote upper airway closure during sleep (4). When there is an obstruction in the upper 
airway, as can be seen in OSA patients, the tidal volume will fall with the consequent decrease 
of the oxygen saturation and an increase in carbon dioxide. Intermittent hypoxia excites 
peripheral arterial chemoreceptors which evoke persistent sympathetic activation. An 
increased sympathetic tone then causes vasoconstriction and tachycardia and the blood 
pressure increases (37).  
As there is an increased respiratory effort against a narrowed or completely blocked 
airway, a reflex bradycardia and atrioventricular block (AV block) may occur. When the apnea 
stops, a recovery tachycardia may develop, and supraventricular and ventricular ectopy may 
occur in susceptible individuals (37). Moreover, increased preload and afterload, left shift of 
the interventricular electrical axis and a reduction in left ventricular compliance might also be 
the consequences. This may result in worsening of preexisting congestive heart failure (37).  
OSA is linked with increased oxidative stress and reactive oxygen species/reactive 
nitrogen species (ROS/RNS) (38). More precisely the hypoxia-induces stress leads to release 
of inflammatory cells, elevation of leptin, reduced fibrinolytic activity and increased platelet 
adhesiveness (37). Also, repetitive hypoxia and reoxygenation causes mitochondria and 
endoplasmic reticulum dysfunction, NADPH oxidase overactivation, xanthine oxidase, 
uncoupling NO synthase and an induced imbalance of the pro-oxidant and antioxidant 
molecules which gives a rise to series of oxidative stress response. In the brain oxidative stress 
can lead to neuron injury and cognitive dysfunction, usually seen in OSA patients (39). It is 
important to point out that oxidative stress occurring due to the long-term intermittent hypoxia 
is further promoting breathing instability by worsening the pharyngeal muscle dilator function 
(37).  
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It is known that OSA has adverse effects on endocrine glands (40-42). The most 
frequent endocrine comorbidity in OSA patients is diabetes mellitus type 2. It can also be seen 
the other way around, that type 2 diabetes patients often develop OSA. Several studies have 
reported that OSA is associated with poorer glycemic control and it is a risk factor for glucose 
dysmetabolism. Moreover, studies using PG/PSG for accurate diagnosis of OSA showed a 
robust positive association between OSA severity and levels of HbA1c in patients with type 2 
diabetes (40). Independent of obesity, OSA is also associated with increased insulin resistance 
and glucose intolerance (41). Intermittent hypoxia, increased sympathetic tone, and 
dysregulation of the hypothalamo-pituitary axis, might be mechanisms linking OSA to insulin 
resistance and impaired glucose tolerance, further leading to diabetes mellitus type 2 (42).  
There is also data suggesting a link between OSA and gestational diabetes and even 
type 1 diabetes, in terms that patients with type 1 diabetes have higher prevalence of OSA than 
the general population (40). In some females, due to hyperinsulinism that shifts the androgen-
estrogen balance of the ovarian hormone synthesis towards the androgen side, polycystic 
ovarian syndrome may appear (37). 
Obesity is the major risk factor for OSA (43), and epidemiological studies have 
demonstrated that there are increased odds of developing OSA when gaining weight. It is 
estimated that 58% of OSA patients with moderate to severe type is due to obesity (43).  
Patients also report a rapid weight gain in the year prior to the OSA diagnosis. Even 
though we do not fully understand the mechanisms underlying the relationship between OSA 
and obesity, some data suggest that sleep deprivation is associated with an increase in appetite 
hormones, further leading to altered eating patterns and weight gain (43). However, fat 
distribution seems to have even more important role than obesity itself and increased waist/hip 
ratio and neck circumference correlates better with OSA severity than obesity in general (4). 
Imaging studies have shown that retropharyngeal fat deposition may reduce the upper airway 
diameter and promote breathing difficulties (37). Nevertheless, weight reduction can reduce 
the severity, or even eliminate OSA in some patients, (37) which is an important aspect. 
Concerning the cardiovascular system, OSA is associated with major pathogenesis 
(44). Cardiac arrhythmias and sudden cardiac death can be seen. Intermittent hypoxia and 
chronic sleep fragmentation may shift the sympatho-vagal balance toward sympathetic 
predominance and a vagal withdrawal. This can further lead to myocardial electric instability. 
It has been shown that OSA patients are susceptible to this adverse sympathoexcitation during 
the REM sleep. There is also seen a difference between genders when it comes to ventricular 
repolarization, where females have longer action potentials, a higher susceptibility to 
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arrhythmias and predisposition to arrhythmogenic effects of some drugs when compared to the 
men of the same age (44). Some studies suggest an association between pulmonary 
hypertension and OSA, but there are still no final conclusions yet (45). 
There is an association between stroke and OSA. Mild OSA was seen in 72% of patients 
following a stroke or transient ischemic attack, and AHI > 20 in 38% of these patients (37).  
Many psychiatric disorders, such as depression and anxiety have been associated with 
OSA (46). A systematic review has shown that the prevalence of depression varied from 7% 
to as much as 63% and anxiety 2.9–70% in OSA patients. The big difference was attributed to 
different factors such as the use of different mood scales. OSA patients with comorbid major 
depression reported longer and more severe episodes of depression when compared to 
depressive patients without OSA, and the CPAP treatment was successful in reduction of 
comorbid depressive symptoms (47). Previous study supports the theory that the more severe 
OSA is, there would be a higher percentage of patients with depression (48), but a study 
performed at Bergen University hospital surprisingly found that increased severity of OSA was 
actually associated with less anxiety and depression (49). In conclusion, the link between 
depression, anxiety and OSA needs to be more profoundly investigated.  
Previous studies have indicated that OSA patients have gastroesophageal reflux disease 
(GERD) symptoms, consisting of heart burning, acid regurgitation and sleep deficiency (50), 
much more frequently than people in the general population (51). The reason might be negative 
intrathoracic pressure gradients which is seen in OSA patients and may lead to symptoms of 
GERD (51). Indeed, it has been shown that around 50% of GERD symptoms that occurred in 
OSA patients were in fact related to the apneas or hypopneas (4). Furthermore, a study using 
endoscopically diagnosed GERD found that GERD was associated to a more severe OSA, and 
that the symptoms of GERD were associated with worsened sleep quality (51). 
 
 
1.3.1.2. Treatment 
There are two major categories of OSA treatment, surgical or non-surgical.  
The surgical treatment might include nasal surgery, hypopharyngeal surgery, oral 
surgery, the hypoglossal nerve stimulation, or tracheostomy in very rare occasions (52). 
Uvulopalatopharyngoplasty (UPPP) is the most common surgical procedure for OSA patients. 
The procedures done in UPPP and the consequences of the surgery on the upper airways are 
shown in Figure 9. This surgery consists of tonsillectomy, reorientation and trimming of 
anterior and posterior tonsillar pillars and excision of posterior palate and uvula (53). 
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A study investigating the effects of UPPP for OSA treatment demonstrated that six-
month post-surgery all patients had significant improvements in sleep properties (snoring 
index, AHI, respiratory distress index, and arterial oxygen saturation) and symptom 
improvements was found in 64% of cases (54).  
 
 
Figure 9. UPPP surgery. 
Taken from MountNittany.org [Internet]. Available from 
https://www.mountnittany.org/articles/healthsheets/6299 (55). 
 
 
Part of the non-surgical treatment is positive airway pressure (PAP), oral applicants, 
drugs, transcutaneous electrical stimulation and positional therapy (52). PAP is the most 
common treatment for OSA. PAP has three modes: continuous positive airway pressure 
(CPAP), bi-level positive airway pressure (BPAP) and auto titrating positive airway pressure 
(APAP) (52). The standard treatment for severe OSA is CPAP (56), and in it shown in Figure 
10 (57).  
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Figure 10. CPAP treatment.  
Taken from Cancercare.com [Internet] Cancer care of western New York. Available from 
https://www.cancercarewny.com (57).    
 
It is usually recommended to patients with an AHI > 30/hour and for symptomatic 
patients (4). Still, it can also be selectively used in the mild and moderate type (52), but the 
benefit of CPAP for mild OSA and no associated medical or psychiatric disorders is more 
uncertain (4). The compliance to the CPAP therapy is 40–80% (52).  
CPAP is able to overrun OSA by keeping the upper respiratory tract open during sleep 
(56). Its functions as a pneumatic splint maintaining patency of the nasopharyngeal airway (4). 
It consists of a CPAP machine which makes the pressure gradients and a tube that transmits 
this pressure to the CPAP mask. The mask can cover only the nose (nCPAP) or nose and mouth 
(full face mask) (58).  
By preventing airway collapse and vibrations, different studies have shown that CPAP 
can improve everything from snoring to awakening, nocturia, wheezing and asphyxia. There is 
also seen improvement in excessive daytime sleepiness and a reduction of car accidents 
following regular CPAP use (52). A number of studies have also suggested that treatment with 
CPAP could attenuate oxidative stress levels in OSA patients (39). Both symptomatic 
improvement and long-term outcomes benefits are found in both meta-analyses and 
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randomized controlled trials investigating effects of CPAP use in OSA treatment (58). It also 
looks like the longer CPAP is used, the better the improvement for long-term prognosis of 
cardiovascular disease is (52). 
The adverse effects of all the PAP`s might be skin rupture, conjunctivitis, nasal 
congestion, airway dryness, pneumothorax, intestinal obstruction (52). If there is an intolerance 
to CPAP, both BPAP and APAP can be used (52). BPAP will give a lower level of expiratory 
positive airway pressure and a higher level of inspiratory positive airway pressure. It can be 
used in older age patients, higher AHI, more pronounced desaturations, higher ESS scores, 
Chronic obstructive pulmonary disease (COPD) and Congestive heart failure (CHF) (52). 
APAP automatically adjust the pressure between 5-20 mmHg. It provides more of both comfort 
and compliance than CPAP. Patients with different comorbidities, like CHF, COPD, or central 
apnea, may not be eligible for APAP (52).  
When the supine sleep AHI is at least twice that of sleeping in a non-supine position, it 
is considered as a type of positional or supine obstructive sleep apnea (4). The airways more 
easily collapse in a supine position and the end-expiratory lung volume is reduced. This reduces 
the negative pressure in the chest and the lung oxygen is reduced (52). The treatment might be 
lying in any other position than supine. The effect is highly depended on the patient's ability to 
find a comfortable non-supine sleep position (52). The therapy traditionally consists of placing 
3-4 tennis balls in a pocket in the back of a pajama top - the tennis ball technique (4), which 
prevents the patients turning to a supine position. Unfortunately, the long-term compliance is 
very poor. In a study less than 10% of the patients continued this technique after 30 months 
(52). There have been different alternatives to the tennis balls, like the cervical pillow (4) 
mattress for prone sleep, vibrotactile positional feedback, but this area needs more research 
(52).  
Oral appliances (OA) are dental splints that keep the mandible in a desirable position 
that prevents the upper airway from collapsing while sleeping. OA are the second most 
common therapy used when treating OSA, first is CPAP. OA are cheap, simple, reversible and 
quiet (56). That is also why many patients prefer them before CPAP. OA are effective in around 
80% of patients that are snoring and patients with mild to moderate OSA and around 30% of 
patients with severe OSA. Positional OSA patients seems to have a higher success rate (4). The 
type of OA used seems to play a role in the effectiveness. The custom-made type has been 
demonstrated more effective than the boil-and-bite type. The adverse effects are dry mouth or 
tooth/gum discomfort, excessive salivation, muscle tenderness and jaw stiffness. The costume 
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made type can remove these adverse effects; otherwise the side effects will usually resolve 
with time (56). 
Rather than to be either or, both CPAP and OA could potentially complement  each 
other. The combination has been reported successful. A study found that patients that where 
compliant to CPAP (> 4 h/night) improved their sleep further once they had an option to use 
OA when they did not use CPAP (59).  
Drug therapy including acetazolamide, medroxyprogesterone, serotonin agents and 
modafinil have all been studied as potential OSA treatment (4). Enhancement of upper airway 
muscle tone during sleep, increase of the ventilatory drive, reduce of REM sleep and alleviation 
of excessive sleepiness are all mechanisms where pharmacologic agents potentially might 
improve OSA signs and symptoms (4). Unfortunately, to this date, there is no single 
pharmacological agent that can be used for primary treatment of OSA (37). More studies are 
needed to fully understand this field.  
As an addition to any therapeutic mode, in general, OSA patients are recommended to 
stop taking certain drugs that are known to worsen or induce apnea. Smoking, alcohol, 
benzodiazepines, narcotics, muscle relaxants and sedatives are all recommended to be stopped. 
It is also important to discuss sleep hygiene and potentially dangerous activities (4).   
 
 
1.3.2. Central sleep apnea  
Central sleep apnea appears due to a temporary failure of the pontomedullary 
pacemaker neurons to generate a breathing rhythm. The inspiratory neural output that is needed 
for the nerves innervating the inspiratory thoracic muscles is not working and this causes stop 
of inspiratory ventilation and absence of naso-oral airflow. The complete absence of more than 
10 seconds is defined as an apnea. The central apneas can occur normally during the sleep onset 
or can be caused by many different disorders like congestive heart failure, opioid treatment etc. 
Central apneas may appear in all ages and both genders (33).   
 
 
1.3.3. Insomnia 
Insomnia is characterized by difficulty falling asleep or difficulty maintaining sleep. 
The most common symptoms can be frequent awakenings, problems returning to sleep after 
awakenings, or waking up too early and not being able to return to sleep (60). There is a feeling 
of not being refreshed after sleep and an impairment of daytime functions. These complaints 
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must have been problematic for at least 4 weeks to be diagnosed as insomnia (61). In the 
general population around 1/3 will experience symptoms of insomnia and 10-15% will meet 
the criteria of the disorder insomnia (62). Out of these around 50% has a chronic type (60).  
The risk factors for insomnia are highly comorbid with psychiatric disorders (63). Other 
risk factors are female sex, older age (> 60 years), night/rotating shift work, traveling across 
time zones, psychosocial distress, pregnancy, poor physical health (congestive heart failure, 
sleep-disordered breathing), poor mental health (depression, anxiety, schizophrenia), substance 
use or medication side effects (62).  
The main diagnostic procedure in assessment of insomnia is whole-night PSG. 
However, a sleeping log or diary can offer an important insight in patients’ signs and symptoms 
and help in insomnia evaluation (64). 
There is evidence suggesting hyperarousal pathophysiology that includes elevated 
cortisol levels and adrenocorticotropic hormone during the early sleep and an elevated whole-
body metabolic rate during both sleep and wakefulness. Increased high frequency EEG activity 
in NREM sleep and a reduced parasympathetic tone in the heart rate variability have also been 
confirmed. Small wake-sleep differences in regional brain metabolism are also found in people 
with insomnia compared to healthy sleep (61).  
The first line therapy of insomnia is cognitive behavioral therapy (CBT) (63). It has 
been shown in different randomized control trials that CBT works better in both short- and 
long-term outcomes in comparison with sleep medicines like e.g. zopiclone. There was an 
improvement in sleep efficiency from 81.4% pretreatment to 90.1% after 6 months. The 
patients using zopiclone, surprisingly, had a decrease in sleep efficiency from 82.3% during 
pretreatment to 81.9% after 6 months (65). CBT consists of sleep hygiene education, including 
regular exercise, balanced diet, avoiding alcohol use and ensuring the proper sleeping 
environment (in terms of noise, temperature and reduced lightning). There is also a strict 
schedule of bedtime and rising time and the time allowed in bed. A part of the CBT is education 
of the patient with the main goal to teach to identify and treat fears and beliefs concerning 
sleep. Insomnia patients are also instructed how to control muscular tension and how to control 
and relax (65).  
 
 
1.3.4. REM sleep behavior disorder (RBD)  
In this disease there is a loss of the mechanisms that cause the atonia and paralysis 
normally seen in REM sleep. The result is inappropriate motor behavior during REM sleep, 
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usually manifested as sporadic limb jerks, kicking and punching. Shouting can also be heard 
(6). 
The pathophysiology of this disease is not currently known. Animal models suggest an 
interruption in REM muscle atonia and disinhibition of brainstem motor pattern generators, 
especially in the pontine tegmentum. In adults with RBD neuroimaging shows evidence of 
structural lesions in the brainstem, implicating the dorsal midbrain and pons (37).  
Unfortunately, many of patients diagnosed with RBD will develop neurodegenerative 
diseases like Parkinson’s disease and Lewi bodies 6-15 years following the RBD diagnosis (6), 
which can suggest that RBD is a neurodegenerative disease itself. RBD can also occur due to 
narcolepsy and OSA or as a side effect of drugs such as antidepressants.  
It is diagnosed using whole night PSG, although some screening questions can help in 
evaluation of RBD patients. The treatment consists of treatment of underlying causes, changing 
in sleep environment and drugs such as melatonin or clonazepam (66). 
 
1.3.5. The most common complaints of patients with sleep disorders 
 Although there is so much difference in etiology and pathophysiology of various sleep 
disorders, sometimes they might present with similar symptoms (5,60). Poor sleep quality and 
excessive daytime sleepiness are among the most common complaints in patients suffering 
from various sleep disorders. Poor sleep quality includes troubles with falling asleep, frequent 
wakening and not feeling refreshed after a sleep. In many cases, the objective corresponding 
parameter of the subjective sleep quality is sleep efficiency. This objective parameter can be 
obtained from the whole-night PSG and represents the quotient between time spent sleeping 
and time spent in bed. It is expressed as percentage and the higher number indicates better sleep 
efficiency. Still, it does not provide any information about sleep architecture and thus cannot 
be sufficient in sleep evaluation (4). Subjective sleep quality can be assessed with different 
questionnaires and scales, with the PSQI being the one of the most frequently used 
questionnaires in assessment of the subjective sleep quality (18-20). Another very prominent 
symptom of the various sleep disorders, especially OSA, is excessive daytime sleepiness, 
resulting from frequent arousals and microarousals related to respiratory events (5). Usually, 
in a clinical setting, the subjective daytime sleepiness is assessed with Epworth sleepiness scale 
(21,22).  
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2. AIM AND HYPOTHESES  
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The aim of this thesis is to compare subjective sleep quality measured by the Pittsburgh 
Sleep Quality Index and excessive daytime sleepiness measured by the Epworth Sleepiness 
Scale with objective whole-night polysomnography findings in OSA patients from Split Sleep 
Medicine Center (SSMC). 
 
Hypoteses: 
 
• Sleep efficiency assessed by whole-night polysomnography will positively correlate 
with sleep quality assessed by Pittsburgh Sleep Quality Index in OSA patients. 
• OSA patients with poor subjective sleep quality assessed by Pittsburgh Sleep Quality 
Index will have impaired sleep architecture. 
• OSA patients with excessive daytime sleepiness will have impaired sleep architecture. 
• OSA severity measured by AHI will positively correlate with excessive daytime 
sleepiness assessed by the Epworth sleepiness scale. 
• OSA severity measured by AHI will positively correlate with subjective sleep quality 
assessed by Pittsburgh Sleep Quality Index. 
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3. SUBJECTS AND METHODS  
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3.1. Subjects 
The subjects recruited in this study are OSA patients from the Split Sleep Medicine 
Center. From 2008-2018 a total of 317 patients diagnosed with OSA by whole night PSG were 
included in this study. Patients who were diagnosed OSA with PG were not included since PG 
does not provide data about sleep architecture and sleep efficiency that were important in this 
research. Adults, both males and females, were included and their ages ranged from 18 to 82 
years. Exclusion criteria were age less than 18 years or the presence of severe mental disability.  
 
 
3.2. Methods 
Prior to going to sleep, the patients filled in the questionnaires, with the assistance of 
the medical staff, if needed. Following completion of the questionnaires, the patients were 
hooked up with the electrodes for PSG and were put in the bed to sleep. 
 
 
3.2.1. Questionnaires 
Epworth Sleepiness Scale (ESS) was used to measure patient's general level of daytime 
sleepiness. This is a subjective test where the patient has to rate on a scale from 0-3 (where 0 
represents no chance of dozing and 3 represents high chance of dozing) if they have dozed in 
8 specific situations over the recent time. These situations are: Sitting and reading, Watching 
TV, Sitting inactive in a public place, Being a passenger in a motor vehicle for an hour or more, 
Lying down in the afternoon, Sitting and talking to someone, Sitting quietly after lunch (no 
alcohol) and Stopped for a few minutes in traffic. The score achieved on the ESS is the sum of 
answers to these eight questions and may be between 0-24, where the higher numbers indicate 
higher daytime sleepiness. A score of 10 or more indicates the presence of excessive daytime 
sleepiness. In this research the Croatian version of the ESS that has been previously validated 
was used (67).  
Pittsburgh sleep quality index (PSQI) consists of 19 items and it offers 7 component 
scores and 1 global score. The 7 components are Subjective sleep quality, Sleep latency, Sleep 
duration, Sleep efficiency, Sleep disturbance, Sleep medicine usage and Daytime function. The 
maximum score that can be achieved on this questionnaire is 21 and the higher scoring numbers 
indicate worse sleep quality. In this study Croatian version of the PSQI was used to assess 
patient's subjective sleep quality (20).  
3.2.2. Polysomnography 
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For the objective view on sleep the whole night PSG was used recorded with Alice 5 
and Alice 6 LDE devices (Philips, Respironics, Amsterdam, The Netherlands). As mentioned 
before, PSG consists of continuous and simultaneous recording of multiple monitors: EEG, 
ECG, EOG and EMG. In EEG, the voltage was recorded from scalp electrodes representing 
summed potential activity of cortex neuronal somas and dendrites. The voltages varied between 
5 and 200 mV and the frequency somewhere between 0.5 and 45 Hz. In this study, the 
international 10-20 system of placement of the electrodes was used and, following the system, 
the electrodes were placed 10 or 20% of the distance to specific landmarks, both on the right 
and the left side of the scalp. 
EOG was used to measure a potential difference between the positively charged cornea 
and the negatively charged retina. Two electrodes were used, one placed 1 cm above and lateral 
to the outer canthus of the eye and the other one 1 cm below and lateral to the outer canthus of 
the other eye according to Rechtschaffen and Kales criteria (37). 
EMG measures the electrical activity of muscle fibers and nerve impulses. Thus, the 
electrodes were attached to the mentalis and submentalis muscles. Additional bipolar 
electrodes were placed on the anterior tibialis muscle to record limb movements. 
PSG recording also included respiration monitoring, by detecting changes in pressure 
between inspiration and expiration in the oronasal airflow, monitoring of the saturation of the 
blood with oxygen by pulse oximeter and monitoring efforts of the thoracic and abdominal 
muscle walls.   
All patients were recorded with whole-night PSG during one night. All the standard 
operative procedures for adults in accredited sleep medicine centers in Europe brought by 
European Sleep Research Society were followed during the PSG recording (68). The PSG 
recordings were automatically scored, but later on they were manually corrected by 
experienced sleep medicine stuff. The data achieved by PSG that was used in this study 
included: AHI indicating OSA severity, sleep efficiency calculated as ratio between time spent 
sleeping and time spent in bed, and sleep architecture expressed as amount of each sleep stage. 
 
 
3.3. Data collection and statistical analysis 
All data, including PSG measures, ESS and PSQI, was collected and summarized in a 
table with the use of Excel software. All statistical procedures were carried out in the MedCalc 
(MedCalc, Ostend, Belgium). Categorical variables were shown as whole numbers and 
percentages and quantitative variables as means and standard deviations. Age was shown as 
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median and minimum and maximum, and the amount of each sleep stage was presented as 
percentage. In comparison of the sleep architecture between mild, moderate and severe OSA 
patients one-way ANOVA was used. Correlations between sleep efficiency and PSQI, between 
ESS score and AHI, as well as AHI and PSQI were expressed with the use of Pearson's 
correlation coefficient. Student’s t-test was used in evaluation of sleep architecture differences 
between good and poor sleepers, and among patients with normal and excessive daytime 
sleepiness. The level of statistical significance was set at P < 0.05. 
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4. RESULTS  
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In the present research a total of 317 patients from the Split Sleep Medicine Center 
(SSMC) were included. 83 females with a median age of 60 and ranging from the age of 20 to 
82 years, and 234 males with a median age of 55, ranging from the age of 18 to 80 years were 
recruited in the study. The demographic data of the study subjects are shown in Table 2.  
 
 
Table 2. Demographic data of the subjects. 
 
 
                                 Female                       Male                                 Total 
                                 N (83)                    N (234)                                 N (317) 
 
Age                          60 (20-82)              55(18-80)                          56 (18-82) 
BMI (kg/m2)           28.28±4.58           29.86±4.45                     29.45±4.53 
Height (cm)             165.30±6.53         180.85±7.21                    176.80±9.80 
Weight (kg)             77.43±13.29         97.82±16.26                 92.481±17.93 
NC (cm)                   37.14±3.47           43.62±3.26                       41.93±4.36  
 
BMI=Body mass index, NC=Neck circumference  
Variables are shown as means ± standard deviations. 
Age is shown as median (min-max). 
 
In Table 3, differences in sleep architecture among patients with mild, moderate and 
severe OSA are shown. Sleep architecture changed with OSA severity, with an increased 
amount of sleep stage N2 (66.41±11.93% in mild OSA, 69.12±11.43% in moderate OSA and 
73.45±14.74% of sleep stage N2 in severe OSA, F = 8.635, P < 0.001; Table 3) and decreased 
amount of deep sleep stage N3 in more severe forms of OSA (11.67±8.89 % in mild OSA, 
11.10±7.35% in moderate OSA and 6.88±7.63 in severe OSA, F = 12.701, P < 0.001; Table 
3).  
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Table 3. Sleep architecture in different severities of OSA. 
 
OSA  
 
                        Mild                        Moderate                  Severe              P*  F-value             
                        5<AHI<15              15<AHI<30             AHI >30 
                        N=107                     N=76                       N=133 
 
N1 (%)             4.83±5.65                5.01±4.80               5.75±9.61        0.607        0.501 
N2 (%)             66.41±11.93            69.12±11.43           73.45±14.74    0.001        8.635 
N3 (%)             11.67±8.89              11.10±7.35              6.88±7.63       0.001       12.701 
REM (%)         17.44±7.90              14.77±8.33              13.81±7.42     0.002       6.412 
Sleep  
efficiency (%)  77.04±13.25           75.80±14.57             80.26±15.96    0.070 2.680 
 
All values are presented as percentages and expressed as means ± standard deviations. 
*Differences are tested with one-way ANOVA 
 
Patients who had decreased sleep efficiency had higher score on PSQI, indicated by a 
negative statistically significant correlation between sleep efficiency assessed by whole night 
polysomnography and subjective sleep quality assessed by PSQI (r = -0.21, P = 0.001; Figure 
11). In the analysis of correlation between sleep efficiency and PSQI score, 3 patients were 
excluded due to the fact that they did not sleep at all.  
Patients suffering from more severe forms of OSA had more pronounced excessive 
daytime sleepiness and the relationship between AHI and score achieved on ESS showed a 
statistically significant positive correlation (r = 0.25, P < 0.001), as shown in Figure 12. 
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Figure 11. Correlation of PSQI and sleep efficiency (N = 239; 242 subjects answered PSQI, 
3 subjects were excluded due to the fact that they had very low sleep efficiency). 
Data were analyzed with Pearson’s correlation coefficient. 
 
 
Figure 12. Correlation of ESS and AHI (N = 315). 
Data were analyzed with Pearson’s correlation coefficient. 
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Figure 13. Sleep architecture in good (PSQI ≤ 5; panel A) and bad sleepers (PSQI > 5; panel 
B). There were no statistically significant differences in the sleep architecture between these 
two groups (P > 0.05). 
1: N1 Sleep 2: N2 Sleep 3: N3 Sleep 4: REM sleep.  
The differences were tested with Student’s t-test for independent samples. 
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An average score achieved on PSQI among all subjects was 9.01 ± 4.11. According to 
the score achieved on the PSQI, all participants were allocated to either a group of good 
sleepers with PSQI score of 5 or less, or to a group of poor sleepers with PSQI score of more 
than 5. In the group of good sleepers, there was a total of 56 patients and 186 patients were in 
the group of poor sleepers. The remaining 75 patients did not fill in the PSQI questionnaire. 
When sleep architecture was compared between these two groups, there were no statistically 
significant differences in the percentage of any sleep stage between the two groups (P = 0.401 
for sleep stage N1, P = 0.811 for sleep stage N2, P = 0.422 for N3 and P = 0.485 for REM 
sleep), as can be seen in Figure 13 A and B. 
The average score that all included patients achieved on ESS was 7.47 ± 4.80. 
According to the achieved result on ESS, patients were considered to have either normal 
daytime sleepiness (ESS score less than 10) or to have excessive daytime sleepiness (ESS of 
10 or more). In total, 218 patients had normal daytime sleepiness, 97 had excessive daytime 
sleepiness assessed by the ESS, and 2 patients did not fill the ESS questionnaire. When sleep 
architecture was examined among groups of patients with normal and excessive daytime 
sleepiness, there were no statistically significant differences (P = 0.125 for stage N1, P = 0.782 
for N2, P = 0.258 for N3 and P = 0.093 for REM sleep), as shown in Figure 14. 
Although not statistically significant, there was a slight negative correlation between 
OSA severity assessed by AHI and subjective sleep quality assessed by PSQI (r = -0.123, P = 
0.057). 
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Figure 14. Sleep architecture in patients with and without excessive daytime sleepiness 
assessed by ESS. Normal daytime sleepiness was considered in case ESS score was <10 and 
excessive daytime sleepiness in case ESS score was ≥10. There were no statistically significant 
differences in sleep architecture among these two groups of patients (P > 0.05). 
The differences were tested with Student’s t-test for independent samples. 
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5. DISCUSSION  
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The main findings of this study indicate that patients suffering from more severe forms 
of OSA experience changes in sleep architecture and more pronounced excessive daytime 
sleepiness. Out of the objective sleep measures, only the sleep efficiency, but not sleep 
architecture of the OSA patients correlated with subjective sleep quality assessed by PSQI. 
Also, there were no differences in sleep architecture among OSA patients with and without 
excessive daytime sleepiness assessed by ESS. 
It is well known that OSA increases duration of light sleep and reduces time spent in 
deep sleep stage (68). The results of the current study are similar, showing the association 
between OSA severity and the prolongation of the stages N1 and N2 and reduction of the stages 
N3 and REM. Respiratory disturbances seen in OSA are followed by reductions in arterial 
blood oxygenation which cause arousals. In such a way, OSA patients spent less time in deep 
sleep stage and more time in light sleep.  
Similarly, it has been established that OSA severity influences daytime sleepiness. The 
most possible underlying mechanism is sleep fragmentation, resulting from repetitive arousals 
in response to breathing disturbances in OSA patients (70). However, no statistically significant 
differences in the sleep architecture were found in this study among patients with normal and 
excessive daytime sleepiness. Only subtle differences were seen in decreased amount of the 
N3 stage in patients with excessive daytime sleepiness, which also might be the consequence 
of frequent microarousals. Thus, it is likely that microarousals as responses to breathing 
cessations in fact slightly decrease the proportion of N3 stage in favor of N2 stage in this study. 
Consequently, the more severe OSA would lead to more frequent arousals and would finally 
result in slightly decreased proportion of stage N3 and increased daytime sleepiness. Findings 
supporting our results, showing the correlation between OSA severity and excessive daytime 
sleepiness, were obtained from the Sleep Heart Health Study, conducted on the community-
dwelling adults (70). However, there is still a controversy on that topic and some studies failed 
to find the correlation between OSA severity and the level of the daytime sleepiness (71). Thus, 
further studies should clarify the role of OSA severity in daytime sleepiness, assessing changes 
in greater amount of participants to draw final conclusions. 
In this study, it was observed that OSA patients had a higher value on the global PSQI 
score when the sleep efficiency was measured low, and, vice versa, the lower score on PSQI 
denoted a higher sleep efficiency. Sleep efficiency, calculated as a proportion of the sleep time 
in time spent in bed, in fact indicates sleep quantity more than sleep quality. The correlation 
found in this research gives the impression that PSQI could be used as a measure of good sleep 
efficiency in OSA patients, although it is mostly to assess the general sleep quality and is not 
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a method used to screen for specific disorders (18). Moreover, even use of PSQI is the most 
common in insomnia patients (19), these results indicate that PSQI can successfully indicate 
insufficient sleep quantity in OSA patients. In this study, sleep quality measured by sleep 
architecture was not significantly different between good and bad sleepers according to PSQI. 
Thus, all taken together might indicate PSQI as a good measure of sleep quantity, but the results 
while assessing sleep quality in OSA patients should be taken with caution. 
This study did not demonstrate any differences in sleep architecture among OSA 
patients with and without excessive daytime sleepiness assessed by ESS. It is important to note 
that even though Epworth sleepiness scale is commonly used to assess daytime sleepiness in 
evaluation of the OSA patients, it is not specific enough to be considered OSA screening test 
(72). Moreover, even though it has excellent properties in measuring excessive daytime 
sleepiness, some of the OSA patients are missing daytime sleepiness as one of the most 
common symptoms. Sleep architecture might be impaired in OSA patients (70), as already 
discussed, but this does not necessarily mean straight-forward association with the excessive 
daytime sleepiness. This is due to the fact that daytime sleepiness is one of the most prominent 
symptoms of OSA and disrupted sleep architecture, which might appear in OSA. However, if 
the same analyses were carried out on the larger sample, maybe an association would be 
discovered. Having this in mind, the Epworth sleepiness scale should be used only as one of 
the instruments in the evaluation of OSA, and definitely not the only one. 
The main complain of OSA patients is usually not decreased sleep quality, but they 
come to seek medical help for snoring. Moreover, OSA patients usually do not complain of 
poor sleep quality and are sometimes unaware, or even denying their problems. The paradox 
of a better perceived sleep quality among patients with more severe forms of OSA is in 
accordance with the finding of Wu et al. who found that more severe hypoxemia is associated 
with better subjective sleep quality among OSA patients (73). The possible explanation of this 
association may be hypoxemia-triggered depression and attenuation of perception, with more 
severe hypoxemia being a concomitant feature of more severe OSA. 
This study had several limitations. First, out of the 317 participants, 75 did not answer 
the PSQI form, so the number of participants was even smaller in some analyses. Second, 
possible comorbidities which frequently appear in OSA patients and usage of medications that 
might influence sleep architecture, daytime sleepiness and sleep quality were not taken into 
consideration. Third, no control group of people with no OSA was composed, so it was not 
possible to compare the results of OSA patients with healthy subjects, but only between 
patients suffering from mild to severe OSA themselves. 
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The main aim of this research was to assess and compare the subjective sleep quality 
and daytime sleepiness and objective whole-night PSG findings in OSA patients. The obtained 
results demonstrated that OSA severity was associated with an impairment of sleep architecture 
and with more pronounced excessive daytime sleepiness. Sleep efficiency, but not sleep 
architecture of OSA patients correlated with subjective sleep quality assessed by PSQI. 
However, no differences in sleep architecture among OSA patients with and without excessive 
daytime sleepiness assessed by ESS were found. 
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6. CONCLUSIONS  
43 
 
1. There is a positive correlation between sleep efficiency assessed by whole-night 
polysomnography and sleep quality assessed by Pittsburgh Sleep Quality Index in 
OSA patients. 
2. There is a positive correlation between OSA severity measured by AHI and 
excessive daytime sleepiness assessed by the Epworth sleepiness scale. 
3. Sleep quality assessed by Pittsburgh Sleep Quality Index does not indicate impaired 
sleep architecture in OSA patients. 
4. The level of daytime sleepiness assessed by Epworth sleepiness scale does not 
indicate impaired sleep architecture in OSA patients. 
5. There is a slight, although not significant, negative correlation between OSA 
severity assessed by AHI and subjective sleep quality assessed by PSQI in OSA 
patients. 
 
  
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. REFERENCES  
45 
 
1. Zhao D, Wang Y, Wang Q, Wang X. Comparative analysis of different characteristics 
of automatic sleep stages. Comput Methods Programs Biomed. 2019;175:53-72. 
2. Dogas Z, Pecotic R, Valic M. Regulation of sleep and wakefulness. In: Bassetti CL, 
Dogas Z, Peigneux P, editors. Sleep Medicine Textbook. Regensburg: European Sleep 
Research Society; 2014. p. 13-27. 
3. Mathis J, de Lacy S, Roth C. Measuring-monitoring sleep and wakefulness. In Bassetti 
CL, Dogas Z, Peigneux P, editors. Sleep Medicine Textbook. Regensburg: European 
Sleep Research Society; 2014. p. 125-44. 
4. Teofilo Lee-Chiong Jr. Sleep medicine Essentials and Review. Oxford University 
Press; 2008. 
5. Sharma M, Goyal D, Achuth PV, Acharya UR. An accurate sleep stages classification 
system using a new class of optimally time-frequency localized three-band wavelet 
filter bank. Comput Biol Med. 2018;98:58-75. 
6. Peever J, Fuller PM. The Biology of REM Sleep. Curr Biol. 2017;27:R1237-48. 
7. Luppi P-H, Adamantidis A, Fort P. Neurophysiology and neurobiology of sleep. In: 
Bassetti CL, Dogas Z, Peigneux P, editors. Sleep Medicine Textbook. Regensburg: 
European Sleep Research Society; 2014. p. 3-12. 
8. Westerterp-Plantenga MS. Sleep, circadian rhythm and body weight: parallel 
developments. Proc Nutr Soc. 2016;75:431-9. 
9. Jagannath A, Taylor L, Wakaf Z, Vasudevan SR, Foster RG. The genetics of circadian 
rhythms, sleep and health. Hum Mol Genet. 2017;26:R128-38. 
10. DeArmond SJ, Fusco MM, Maynard MD. Structure of the Human Brain: A 
Photographic Atlas. 3rd ed. Oxford, New York; 1989. 
11. Chiu HY, Chen PY, Chuang LP, Chen NH, Tu YK, Hsieh YJ et al. Diagnostic 
accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness 
scale in detecting obstructive sleep apnea: A bivariate meta-analysis. Sleep Med Rev. 
2017;36:57-70. 
12. Tan A, Yin JD, Tan LW, van Dam RM, Cheung YY, Lee CH. Using the Berlin 
questionnaire to predict obstructive sleep apnea in the general population. J Clin Sleep 
Med. 2017;13:427–32.  
13. Senaratna CV, Perret JL, Matheson MC, Lodge CJ, Lowe AJ, Cassim R et al. Validity 
of the Berlin questionnaire in detecting obstructive sleep apnea: A systematic review 
and meta-analysis. Sleep Med Rev. 2017;36:116-24. 
46 
 
14. Khaledi-Paveh B, Khazaie H, Nasouri M, Ghadai MR, Tahmasian M. Evaluation of 
Berlin Questionnaire Validity for Sleep Apnea Risk in Sleep Clinic Populations. Basic 
Clin Neurosci. 2016;7:43-8. 
15. Thurtell MJ, Bruce BB, Rye DB, Newman NJ, Biousse V. The Berlin questionnaire 
screens for obstructive sleep apnea in idiopathic intracranial hypertension. J 
Neuroophthalmol. 2011;31:316-9. 
16. Nagappa M, Liao P, Wong J, Auckley D, Ramachandran SK, Memtsoudis S et al. 
Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep 
Apnea among Different Populations: A Systematic Review and Meta-Analysis. PLoS 
one. 2015;10:e0143697. 
17. Chung F, Abdullah HR, Liao P. STOP-Bang Questionnaire: A Practical Approach to 
Screen for Obstructive Sleep Apnea. Chest. 2016;149:631-8. 
18. Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The 
Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and 
non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev. 
2016;25:52-73. 
19. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep 
Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 
1989;28:193-213. 
20. Lusic Kalcina L, Valic M, Pecotic R, Pavlinac Dodig I, Dogas Z. Good and poor 
sleepers among OSA patients: sleep quality and overnight polysomnography findings. 
Neurol Sci. 2017;38:1299-306. 
21. Doneh B. Epworth Sleepiness Scale. Occup Med (Lond). 2015;65:508. 
22. Penzel T, Zucconi M. Assessment of sleep disorders and diagnostic procedures. In: 
Bassetti CL, Dogas Z, Peigneux P, editors. Sleep Medicine Textbook. Regensburg: 
European Sleep Research Society; 2014. p. 95-145. 
23. Herscovitch J, Broughton R. Sensitivity of the stanford sleepiness scale to the effects 
of cumulative partial sleep deprivation and recovery oversleeping. Sleep. 1981;4:83-
91. 
24. Hirshkowitz M. Polysomnography Challenges. Sleep Med Clin. 2016;11:403-11. 
25. Bosi M, De Vito A, Vicini C, Poletti V. The role of compact 
polysomnography/polygraphy in sleep breathing disorder patients' management. Eur 
Arch Otorhinolaryngol. 2017;274:2013-28. 
47 
 
26. Amsleep.org [Internet] The American sleep apnea society [cited 2019 June]. Available 
from https://amsleep.org/.  
27. Swanson CM, Kohrt WM, Buxton OM, Everson CA, Wright KP, Orwoll ES et al. The 
importance of the circadian system & sleep for bone health. Metab Clin Exp. 
2018;84:28-43. 
28. Saad AMJ, Hiyasat D, Jaddou H, Obeidat N. The prevalence of high risk obstructive 
sleep apnoea among patients with type 2 diabetes in Jordan. Diabetes Res Clin Pract. 
2019 9;152:16-22. 
29. Rezaeitalab F, Moharrari F, Saberi S, Asadpour H, Rezaeetalab F. The correlation of 
anxiety and depression with obstructive sleep apnea syndrome. J Res Med Sci. 
2014;19:205-10. 
30. MayoClinic.org [Internet]. May Clinic. [cited 2019 June]. Available from 
https://www.mayoclinic.org/diseases-conditions/obstructive-sleep-apnea/symptoms-
causes/syc-20352090. 
31. Kristiansen HA, Kværner KJ, Akre H, Øverland B, Sandvik L, Russell MB. Sleep 
apnoea headache in the general population. Cephalalgia. 2012;32:451-8. 
32. Maspero C, Giannini L, Galbiati G, Rosso G, Farronato G. Obstructive sleep apnea 
syndrome: a literature review. Minerva Stomatol. 2015;64:97-109. 
33. Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol. 2013;3:141-63. 
34. Mukherjee S, Saxena R, Palmer LJ. The genetics of obstructive sleep apnoea. 
Respirology. 2018;23:18-27. 
35. Garbarino S. Obstructive sleep apnea (OSA) and driving safety. Med Lav. 
2017;108:297-303. 
36. Liu Y, Zou J, Li X, Zhao X, Zou J, Liu S et al. Effect of the Interaction between 
Obstructive Sleep Apnea and Lipoprotein(a) on Insulin Resistance: A Large-Scale 
Cross-Sectional Study. J Diabetes Res. 2019;2019:9583286. 
37. Avidan AY, Barkoukis TJ. Review of sleep medicine. 3rd ed. Philadelphia: Elsevier 
Saunders; 2012. 
38. Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia--
revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev. 
2015;20:27-45. 
39. Zhou L, Chen P, Peng Y, Ouyang R. Role of Oxidative Stress in the Neurocognitive 
Dysfunction of Obstructive Sleep Apnea Syndrome. Oxid Med Cell Longev. 
2016;2016:9626831. 
48 
 
40. Reutrakul S, Mokhlesi B. Obstructive Sleep Apnea and Diabetes: A State of the Art 
Review. Chest. 2017;152:1070-86. 
41. Saad AMJ, Hiyasat D, Jaddou H, Obeidat N. The prevalence of high risk obstructive 
sleep apnoea among patients with type 2 diabetes in Jordan. Diabetes Res Clin Pract. 
2019;152:16-22. 
42. Tasali E, Van Cauter E, Hoffman L, Ehrmann DA. Impact of obstructive sleep apnea 
on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. 
J Clin Endocrinol Metab. 2008;93:3878-84. 
43. Hamilton GS, Joosten SA. Obstructive sleep apnoea and obesity. Aust Fam Physician. 
2017;46:460-3.  
44. Viigimae M, Karai D, Pilt K, Polo O, Huhtala H, Meigas K et al. Influence of gender 
on the QT interval variability and duration in different wake-sleep stages in non-sleep 
apneic individuals: Analysis of polysomnographic recordings. J Electrocardiol. 
2017;50:444-9. 
45. Ismail K, Roberts K, Manning P, Manley C, Hill NS. OSA and pulmonary 
hypertension: time for a new look. Chest. 2015;147:847-61. 
46. Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a 
systematic review. J Clin Sleep Med. 2015;11:165-75. 
47. Hobzova M, Prasko J, Vanek J, Ociskova M, Genzor S, Holubova M et al. Depression 
and obstructive sleep apnea. Neuro Endocrinol Lett. 2017;38:343-52. 
48. Lee SA, Yoon H, Kim HW. Is severe obstructive sleep apnea associated with less 
depressive symptoms. J Psychosom Res. 2019;122:6-12. 
49. Bjorvatn B, Rajakulendren N, Lehmann S, Pallesen S. Increased severity of 
obstructive sleep apnea is associated with less anxiety and depression. J Sleep Res. 
2018;27:e12647. 
50. Oh JH. Gastroesophageal reflux disease: recent advances and its association with 
sleep. Ann N Y Acad Sci. 2016;1380:195-203. 
51. Kim Y, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee JH et al. Associations between 
obstructive sleep apnea severity and endoscopically proven gastroesophageal reflux 
disease. Sleep Breath. 2018;22:85-90. 
52. Tingting X, Danming Y, Xin C. Non-surgical treatment of obstructive sleep apnea 
syndrome. Eur Arch Otorhinolaryngol. 2018;275:335-46. 
49 
 
53. Khan A, Ramar K, Maddirala S, Friedman O, Pallanch JF, Olson EJ. 
Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: the mayo 
clinic experience. Mayo Clin Proc. 2009;84:795-800. 
54. Baradaranfar MH, Edalatkhah M, Dadgarnia MH, Atighechi S, Behniafard N, 
Mirvakili A et al. The effect of uvulopalatopharyngoplasty with tonsillectomy in 
patients with obstructive sleep apnea. Indian J Otolaryngol Head Neck Surg. 
2015;67:29-33. 
55. MountNittany.org [Internet] [cited 2019 June]. Available from  
https://www.mountnittany.org/articles/healthsheets/6299  
56. Lorenzi-Filho G, Almeida FR, Strollo PJ. Treating OSA: Current and emerging 
therapies beyond CPAP. Respirology. 2017;22:1500-7. 
57. Cancercare.com [Internet] Cancer care of western New York. [cited 2019 June]. 
Available from https://www.cancercarewny.com 
58. Virk JS, Kotecha B. When continuous positive airway pressure (CPAP) fails. J Thorac 
Dis. 2016;8:E1112-E1121.  
59. Almeida FR, Mulgrew A, Ayas N, Tsuda H, Lowe AA, Fox N et al. Mandibular 
advancement splint as short-term alternative treatment in patients with obstructive 
sleep apnea already effectively treated with continuous positive airway pressure. J Clin 
Sleep Med. 2013;9:319-24. 
60. Buysse DJ. Insomnia. JAMA. 2013;309:706-16. 
61. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M et al. The 
hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med 
Rev. 2010;14:19-31. 
62. Zhou ES, Gardiner P, Bertisch SM. Integrative Medicine for Insomnia. Med Clin 
North Am. 2017;101:865-79. 
63. Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in 
psychiatric populations: a systematic review. Int Rev Psychiatry. 2014;26:205-13. 
64. Burman D. Sleep Disorders: Insomnia. FP Essent. 2017;460:22-8. 
65. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G et al. Cognitive 
behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older 
adults: a randomized controlled trial. JAMA. 2006;295:2851-8. 
66. Matar E, Lewis SJ. REM sleep behaviour disorder: not just a bad dream. Med J Aust. 
2017;207:262-8. 
50 
 
67. Pecotic R, Dodig IP, Valic M, Ivkovic N, Dogas Z. The evaluation of the Croatian 
version of the Epworth sleepiness scale and STOP questionnaire as screening tools for 
obstructive sleep apnea syndrome. Sleep Breath. 2012;16:793-802. 
68. Fischer J, Dogas Z, Bassetti CL, Berg S, Grote L, Jennum P, et al. Standard procedures 
for adults in accredited sleep medicine centres in Europe. J Sleep Res. 2012;21:357-
68. 
69. Shahveisi K, Jalali A, Moloudi MR, Moradi S, Maroufi A, Khazaie H. Sleep 
Architecture in Patients With Primary Snoring and Obstructive Sleep Apnea. Basic 
Clin Neurosci. 2018;9:147-56. 
70. Gottlieb DJ, Whitney CW, Bonekat WH, Iber C, James GD, Lebowitz M, et al. Relation 
of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J 
Respir Crit Care Med. 1999;159:502-7. 
71. Bausmer U, Gouveris H, Selivanova O, Goepel B, Mann W. Correlation of the Epworth 
Sleepiness Scale with respiratory sleep parameters in patients with sleep-related 
breathing disorders and upper airway pathology. Eur Arch Otorhinolaryngol. 
2010;267:1645-8. 
72. Hesselbacher S, Subramanian S, Allen J, Surani S, Surani S. Body mass index, gender, 
and ethnic variations alter the clinical implications of the Epworth sleepiness scale in 
patients with suspected obstructive sleep apnea. Open Respir Med J. 2012;6:20-7. 
73. Wu MN, Lai CL, Liu CK, Liou LM, Yen CW, Chen SC, et al. More severe hypoxemia 
is associated with better subjective sleep quality in obstructive sleep apnea. BMC Pulm 
Med. 2015;15:117. 
  
51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. SUMMARY 
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Objectives: Obstructive sleep apnea (OSA) is a disorder characterized by repetitive 
cessations of breathing during sleep. One of the most prominent symptoms of OSA is excessive 
daytime sleepiness, associated with micro arousals from sleep which are caused by respiratory 
events. Another feature of the OSA linked to respiratory related arousals might be impaired 
sleep architecture resulting in decreased subjective sleep quality. The main aim of this research 
was to assess and compare the subjective sleep quality and daytime sleepiness and objective 
whole-night polysomnography findings in OSA patients. 
Patients and methods: A total of 317 adult OSA patients from the Split Sleep Medicine 
Center, with an age range from 18 to 82 years, were included in this study. All the patients 
filled in the questionnaires: Epworth sleepiness scale (ESS), assessing daytime sleepiness, and 
Pittsburgh Sleep Quality Index (PSQI), assessing subjective sleep quality. Following 
completion of the questionnaires, the patients underwent whole-night polysomnography. 
Results: Sleep architecture changed with OSA severity, with an increased amount of 
sleep stage N2 (66.41 ± 11.93% in mild OSA, 69.12 ± 11.43% in moderate OSA and 73.45 ± 
14.74% of sleep stage N2 in severe OSA, F = 8.635, P < 0.001) and decreased amount of deep 
sleep stage N3 in more severe forms of OSA (11.67 ± 8.89 % in mild OSA, 11.10 ± 7.35% in 
moderate OSA and 6.88 ± 7.63 in severe OSA, F = 12.701, P < 0.001). There was also a 
correlation between OSA severity and excessive daytime sleepiness assessed by ESS (r = 0.25, 
P < 0.001). Patients who had poorer sleep efficiency had worse subjective sleep quality 
assessed by PSQI (r = -0.21, P = 0.001). There were no statistically significant differences in 
sleep architecture among patients with good and bad sleep quality according to PSQI (P > 
0.05), and among those with normal and excessive daytime sleepiness, according to ESS (P > 
0.05). 
Conclusions: The obtained results demonstrated that OSA severity was associated with 
an impairment of the sleep architecture and with more pronounced excessive daytime 
sleepiness. Sleep efficiency, but not the sleep architecture of OSA patients correlated with 
subjective sleep quality assessed by PSQI. However, no differences in sleep architecture among 
OSA patients with and without excessive daytime sleepiness assessed by ESS were found. 
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9. CROATIAN SUMMARY  
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Hrvatski naslov: Usporedba subjektivne kvalitete spavanja i dnevne pospanosti s 
nalazima cjelonoćne polisomnografije u pacijenata s opstrukcijskom apnejom tijekom spavanja 
Ciljevi: Opstrukcijska apneja tijekom spavanja (OSA) poremećaj je obilježen 
ponavljanim prekidima disanja tijekom spavanja. Jedan od najistaknutijih simptoma OSA-e je 
prekomjerna dnevna pospanost, povezana s mikrobuđenjima koja su uzrokovana respiratornim 
događajima. Još jedna značajka OSA-e izazvana buđenjima može biti narušena arhitektura 
spavanja koja bi mogla rezultirati smanjenom subjektivnom kvalitetom spavanja. Glavni cilj 
ovog istraživanja bio je procijeniti i usporediti subjektivnu kvalitetu spavanja i dnevnu 
pospanost te objektivne polisomnografske nalaze u OSA bolesnika. 
Pacijenti i postupci: Ukupno 317 odraslih OSA pacijenata iz splitskog Centra za 
medicinu spavanja, u dobi od 18 do 82 godine, uključeno je u ovu studiju. Svi pacijenti popunili 
su upitnike: Epworthovu ljestvicu pospanosti (ESS) koja procjenjuje dnevnu pospanost i 
Pittsburghški indeks kvalitete spavanja (PSQI) koji procjenjuje subjektivnu kvalitetu spavanja. 
Nakon popunjavanja upitnika, pacijenti su podvrgnuti cjelonoćnoj polisomnografiji. 
Rezultati: Težina OSA-e utjecala je na arhitekturu spavanja, posebice povećanjem 
količine N2 stadija spavanja (66,41 ± 11,93% u blagoj OSA-i, 69,12 ± 11,43% u umjerenoj 
OSA-i i 73,45 ± 14,74% u teškoj OSA-i; F = 8,635, P < 0.001) i smanjenjem količine dubokog 
spavanja N3 u težim oblicima OSA-e (11,67 ± 8,89% u blagoj OSA-i, 11,10 ± 7,35% u 
umjerenoj OSA-i i 6,88 ± 7,63 u teškoj OSA-i; F = 12,701, P < 0.001). Postojala je i korelacija 
između težine OSA-e i prekomjerne dnevne pospanosti procijenjene pomoću ESS (r = 0,25, P 
< 0.001). Lošija subjektivna kvaliteta spavanja procijenjena pomoću PSQI bila je povezana s 
manjom učinkovitošću spavanja (r = -0,21, P = 0,001). Nije bilo statistički značajnih razlika u 
arhitekturi spavanja u bolesnika s dobrom i lošom kvalitetom spavanja prema PSQI-u (P > 
0,05), te među onima s normalnom i prekomjernom dnevnom pospanošću, prema ESS-u (P > 
0,05). 
Zaključci: Dobiveni rezultati pokazali su da je težina OSA-e povezana s narušenom 
arhitekturom spavanja i s izraženijom dnevnom pospanošću. Učinkovitost spavanja, ali ne i 
arhitektura spavanja OSA bolesnika bila je u korelaciji sa subjektivnom kvalitetom spavanja 
procijenjenom pomoću PSQI-ja. Međutim, nisu nađene razlike u arhitekturi spavanja u OSA 
bolesnika sa i bez prekomjerne dnevne pospanosti procijenjene pomoću ESS. 
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